19-18175320-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006332.5(IFI30):c.325G>A(p.Val109Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000107 in 1,590,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006332.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFI30 | NM_006332.5 | c.325G>A | p.Val109Ile | missense_variant | 3/7 | ENST00000407280.4 | NP_006323.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFI30 | ENST00000407280.4 | c.325G>A | p.Val109Ile | missense_variant | 3/7 | 1 | NM_006332.5 | ENSP00000384886.1 | ||
ENSG00000268173 | ENST00000593731.1 | n.*1761G>A | non_coding_transcript_exon_variant | 21/25 | 2 | ENSP00000471914.1 | ||||
ENSG00000268173 | ENST00000593731.1 | n.*1761G>A | 3_prime_UTR_variant | 21/25 | 2 | ENSP00000471914.1 | ||||
IFI30 | ENST00000600463.1 | n.1064G>A | non_coding_transcript_exon_variant | 2/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000190 AC: 4AN: 210998Hom.: 0 AF XY: 0.0000263 AC XY: 3AN XY: 114188
GnomAD4 exome AF: 0.0000111 AC: 16AN: 1438382Hom.: 0 Cov.: 34 AF XY: 0.0000182 AC XY: 13AN XY: 713274
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2024 | The c.325G>A (p.V109I) alteration is located in exon 3 (coding exon 3) of the IFI30 gene. This alteration results from a G to A substitution at nucleotide position 325, causing the valine (V) at amino acid position 109 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at